Latest Period
n/a
Security Snapshot
Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) Institutional Ownership
CUSIP: 45781K105
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
- Shares outstanding
- 93,811,670
Quick Takeaways
- 45781K105 - Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) is tracked under CUSIP 45781K105.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Quarterly ownership records are not available yet for this CUSIP.
- This page updates as SEC-backed holdings history becomes available.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 45781K105?
CUSIP 45781K105 identifies 45781K105 - Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue With The Right Next Step
- Latest 13F filings - identify new institutional portfolio moves.
- Latest Schedule 13D/13G reports - cross-check beneficial ownership events.
- All institutional ownership pages - compare nearby CUSIPs and holder concentration.
Significant Owners of Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sanofi | 9% | 8,345,387 | SANOFI | 23 Apr 2025 | ||||
| ASTRAZENECA PLC | 8.3% | 7,825,501 | AstraZeneca PLC | 22 Dec 2025 | ||||
| Bpifrance Participations SA | 7.9% | 7,319,429 | Caisse des depots et consignations | 25 Apr 2025 | ||||
| NOVO NORDISK A S | 5% | -35% | 4,718,727 | -36% | Novo Nordisk A/S | 31 Mar 2026 |